Coalition calls on Congress to oppose “poison pill” bill that would undo significant Supreme Court rulings on patent abuse and ultimately lead to increased prescription drug prices and reduced access to life-saving treatments   WASHINGTON, D.C. –  The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market […]

Continue Reading

Journal of Law and the Biosciences Robin Feldman Published: 07 December 2018 Abstract Presenting the first comprehensive study of evergreening, this article examines the extent to which evergreening behavior—which can be defined as artificially extending the protection cliff—may contribute to the problem. The author analyses all drugs on the market between 2005 and 2015, combing […]

Continue Reading

WHAT YOU NEED TO KNOW Thanks to the bipartisan efforts of U.S. Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT), who are among those in both parties working to end Big Pharma’s exploitation of American patients, the big drug companies are on the defensive as support grows to address Big Pharma’s rampant patent abuse. On […]

Continue Reading

N CASE YOU MISSED IT: On Wednesday, Law360 published the below op-ed by intellectual property attorneys Stacie Ropka, Ted Mathias, and Chantelle Ankerman. Their op-ed highlights Big Pharma’s use of patent thickets to abuse the patent system and details how drugmaker Abbive has erected patent thickets around its best-selling drug, Humira. Humira was first licensed by the Food and […]

Continue Reading

IN CASE YOU MISSED IT: Yesterday, Axios highlighted a report from the Institute for Clinical and Economic Review (ICER), which found that drugmakers are not raising the prices on their products due to increased quality or safety, but simply because they can. For example, Humira, the world’s best-selling prescription drug, saw a $1.9 billion increase in net spending attributable […]

Continue Reading

WHAT YOU NEED TO KNOW In case you missed it, Michael Carrier, professor of law at Rutgers Law School and Genevieve Tung, associate director of the Rutgers Law Library, published an op-ed in Stat News on September 26 debunking Big Pharma’s disingenuous opposition of reforming the patent system. The pair encourages lawmakers to stand up to Big […]

Continue Reading

IN CASE YOU MISSED IT: Yesterday, STAT News published the below op-ed by Michael Carrier, professor of law at Rutgers Law School and Genevieve Tung, associate director of the Rutgers Law Library. In their op-ed, Carrier, coming off his important testimony last week to the Health Subcommittee of House Committee on Energy & Commerce, and Tung debunk Big Pharma’s disingenuous […]

Continue Reading

WHAT YOU NEED TO KNOW • During a recent Senate Hearing, Big Pharma and its ally, U.S. Senator Chris Coons (D-DE) continued their push for the STRONGER Patents Act, a harmful piece of legislation that would open the open the door for Big Pharma to expand their already out-of-control patent abuse. • During the same […]

Continue Reading

Commends Committee members for exposing Big Pharma’s efforts to abuse the U.S. patent system & deny patient access to more affordable generic medications and life-saving treatments WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement today in response […]

Continue Reading

IN CASE YOU MISSED IT: Yesterday, Morning Consult published the below op-ed by Matthew Lane, executive director of the Coalition Against Patent Abuse. In this must-read piece, Lane praises the ongoing bipartisan efforts of Senators Richard Blumenthal (D-CT) and John Cornyn (R-TX) to rein in Big Pharma’s exploitation of the patent system. However, Lane argues that Congress must […]

Continue Reading

IN CASE YOU MISSED IT: The Washington Examiner published the below op-ed on Friday by Charles Duan, Director of Technology and Innovation Policy at the R Street Institute, examining many ways the STRONGER Patents Act would be disastrous for the patent system, enabling Big Pharma to expand their rampant patent abuse, and for American patients, who will […]

Continue Reading

IN CASE YOU MISSED IT: CNN published the op-ed below today by Lincoln Network co-founder, Garrett Johnson and Innovation Defense Foundation president, Wayne Brough highlighting the importance of inter partes review (IPR) for canceling invalid patents which are a significant cause of the drug pricing crisis facing American patients. This op-ed echoes what CAPA has told lawmakers, that IPR is essential […]

Continue Reading